3SOF

Watch for bounce. This company is on stealth mode at the moment but watch for breakout soon as white candles start forming. Bounce is due here soon. The company has great potential going into 2006. They are in an industry that is expected to branch out in the near future. Undervalued company deserves some attention. Heres a little more on Calbatech:

CalbaTech is focused on developing and providing products and platforms to the research market, both for biotech and pharmaceutical companies, as well as academic institutions. In addition to growth through acquisition, CalbaTech, comprised of three divisions, Molecular Applications, Research Reagents, and Cellular Therapeutics, is building an experienced and innovative scientific staff, including several notable members of its Scientific Advisory Board that intend to contribute innovation in areas of biological discovery.

interesting !

2005-12-20 05:00:11 
CalbaTech's Subsidiary, LifeStem, Inc., Contracts With Solana MedSpas to Exclusively Offer Its Stem Cell Microbank(TM) to Bank Adult Stem Cells Through Solana MedSpas' National Network 

IRVINE, Calif., Dec. 20 /PRNewswire-FirstCall/ -- CalbaTech, Inc.
(OTC Bulletin Board: CLBE), an emerging life sciences company
(http://www.calbatech.com) concentrating on providing products and platforms
to the research market for biotech and pharmaceutical companies and to
academic institutions, today announced that its wholly owned subsidiary,
LifeStem, Inc., has reached an agreement with Solana MedSpas
(http://www.solanamedspas.com), the nation's foremost developer and syndicator
of medical spas, to exclusively offer LifeStem's Stem Cell MicroBank(TM)
Service through Solana MedSpas' national network.
In the definitive agreement, LifeStem's Stem Cell MicroBank(TM) will
initially be offered in six Solana MedSpas network locations in Southern
California. Solana MedSpas expects to have as many as 70 locations open by
the end of 2006 and intends to offer the Stem Cell Microbank Service at all
locations. "We are extremely pleased that we have formalized an agreement
with Solana MedSpas," says LifeStem President Dan Fulkerson, "and are
confident that many individuals within the Solana MedSpas client base will
take advantage of our Stem Cell MicroBank(TM) Service."
Fulkerson continued, "By beginning with six locations and by adding new
locations as Solana MedSpas debuts them, our conservative estimates over the
first 12 months of operations project revenues in excess of $3 million, with
the potential to exceed $25 million in the next couple of years. We're
looking forward to expanding our microbanking model into the growing Solana
MedSpas network."
In addition to serving the Solana MedSpas client base, LifeStem is
planning an aggressive marketing program of its Stem Cell Microbank(TM)
Service, outside of Solana's efforts, which will reach more potential clients.
"We are delighted to finalize our agreement with LifeStem," says John
Buckingham, CEO and co-founder of Irvine, Calif.-based Solana MedSpas. "We
are now ready to move to the beta test phase at selected medspa locations,"
Buckingham adds, noting that Solana MedSpas will the first medspa network to
offer an adult stem cell collection service. "As Solana MedSpas continue to
orchestrate the marriage of healthcare product innovation with our ever
expanding medspa distribution channel, the addition of LifeStem's Stem Cell
MicroBank(TM) Service to our locations, not only positions Solana MedSpas as
unique vis-a-vis the competition, but it represents the next logical step in
the realization of our vision and mission as a syndicator of medical spas."
About CalbaTech

Recent contract is only one of multiple contracts expected to be announced in the upcoming months. I truly think the price on this stock will appreciate soon. Quaterly profits are already looking good and the company is forecasting record breaking profits in '06.

The market for stem cell technology is currently $500 million, and has been estimated to grow to $30 billion by the year 2010 due to the growth of new cellular therapeutics as well as clinical applications. LifeStem's strategy is to leverage CalbaTech's infrastructure of companies to obtain a leadership position in the emerging stem cells arena and become a preferred provider of adult stem cells to the clinical researcher as part of a comprehensive package of stem cell based services.

Happy Holidays all.

Doing more research on my companies..

The market for stem cell technology is currently $500 million, and has been estimated to grow to $30 billion by the year 2010 due to the growth of new cellular therapeutics as well as clinical applications. LifeStem's strategy is to leverage CalbaTech's infrastructure of companies to obtain a leadership position in the emerging stem cells arena and become a preferred provider of adult stem cells to the clinical researcher as part of a comprehensive package of stem cell based services.

The one thing about high quality penny stocks is that they rarely ever run high and fast at the same time. Most are slow growth but strong investments to certain levels. As science progresses, anyone can see that stem cell technology is going to be a major contributor but many here may believe that is all CalbaTech does and that's not true. They are deep into DNA and molecular research also.
CalbaTech is pursuing a strategy of combining products and technologies, and the companies that provide them, into the following divisions: 1) Molecular Applications; 2) Research Reagents; and 3) Cellular Therapeutics. By pursuing such a strategy, each division should produce value added and increasing returns on shareholders' investment through cross marketing of products and geographic expansion, as well as to achieve product enhancement and efficiency.


http://www.agoracom.com/brokerfactsheet/clbebfs12.pdf

For both long holders and short term traders, I think this will be one last chance to accumulate shares at this price. This stock is setting up for a trend reversal and nice forward momentum. Early next year, they are expected to report solid net profits for 05. Friday, a bullish candle was formed, indicating that this could be setting up for a change in direction..

http://www.americanbulls.net/StockPage.asp?CompanyTicker=CLBE&MarketTicker=OTC&TYP=S

http://biz.yahoo.com/e/051223/clbe.ob8-k.html

Great Tax-Selling buying opportunity! 2006 will be explosive for stem cell stocks! I am back in with a .02325 average... Great long term prostects and also been a Great trading stock this past year... GLTA

Quote from: B Hathaway on December 26, 2005, 11:01:12 AM
For both long holders and short term traders, I think this will be one last chance to accumulate shares at this price. This stock is setting up for a trend reversal and nice forward momentum. Early next year, they are expected to report solid net profits for 05. Friday, a bullish candle was formed, indicating that this could be setting up for a change in direction..

http://www.americanbulls.net/StockPage.asp?CompanyTicker=CLBE&MarketTicker=OTC&TYP=S

http://biz.yahoo.com/e/051223/clbe.ob8-k.html

Resistence Levels... strong resistence at .03 then we will trade to the .05 level rather easily...then not much resistence upwards and that will be later this year or depending on how fast they get operations going especially with the agressive promoting of the LifeStem Stem Cell MicroBank service...GLTA

resist. 0.22 9
resist. 0.20 3
resist. 0.15 2
resist. 0.08 2
resist. 0.07 4
resist. 0.05 11
resist. 0.03 34

Quote from: GatewayStocks on December 28, 2005, 02:07:40 PM
Great Tax-Selling buying opportunity! 2006 will be explosive for stem cell stocks! I am back in with a .02325 average... Great long term prostects and also been a Great trading stock this past year... GLTA[/b]

Yes, I agree Gateway,

This company has strong potential going into 2006. With new p/r's rumored to be out soon, bothe investors and traders will realize that this company is no fluke. Look for substantial net profits coming and do your own DD to understand why shareholders like me are anticipating a colossal sales growth report for 2005. Rumor has it that this setting up for a nice run real soon. Reversal day confirmed today with previous day low being followed by a higher close than the previous day's high. Huge volume this week also confirms that this stock is getting a lot of attention.   

This is a 3 year Chart...looks like it is in a long term downtrend...i will stay away

Ket,

Calbatech, Inc. (CLBE) is poised to emerge ahead of its current condition starting early next year. The stock has been depreciated this past year due to poor net income for 2004. This year however, they have reported positive record earning statements and are projecting even greater earnings growth for 2006. They hold numerous patents on all of its proprietary technologies. Their subsidiary, Lifestem, Inc. is acquiring more contracts to whom they can offer their Stem Cell Microbank. Calbatech has opened the doors for great opportunities for 2006. Here are some of their key numbers:

Company Type   Public (OTC: CLBE)

Fiscal Year-End   December
2004 Sales (mil.)--   $0.3
1-Year Sales Growth--   2,408.3%
2004 Net Income (mil.)--   ($2.7)
2004 Employees--   19
1-Year Employee Growth--   137.5%

+21% Watch for strong trend to continue next week. Volume has been strong all week. Still not too late to get in as we expect good news from this company soon! No time to hesitate. Discounted shares wont last. 

broke .03 resistence HOD .034... Looking good going into next year... no tax selling/selling of any kind last 2 days to speak of. That .03 break today was huge

B Hathaway...I agree, Microbank contracts will come from all over if they promote agressivily as they stated they will... I can't make projections but the way it is set up there could be dosens of deals just on microbank alone...This doesn't even include their other products and patents... CLBE was about the only stem cell stock up the past 2 days... I look for great news coming very soon and a continous flow...Numbers for 2005 mark a distinct turnaround year for CLBE and 06 is 10 times more promising with the groundwork laid...GLTA

Quote from: B Hathaway on December 30, 2005, 05:00:14 AM
Ket,

Calbatech, Inc. (CLBE) is poised to emerge ahead of its current condition starting early next year. The stock has been depreciated this past year due to poor net income for 2004. This year however, they have reported positive record earning statements and are projecting even greater earnings growth for 2006. They hold numerous patents on all of its proprietary technologies. Their subsidiary, Lifestem, Inc. is acquiring more contracts to whom they can offer their Stem Cell Microbank. Calbatech has opened the doors for great opportunities for 2006. Here are some of their key numbers:

Company Type   Public (OTC: CLBE)

Fiscal Year-End   December
2004 Sales (mil.)--   $0.3
1-Year Sales Growth--   2,408.3%
2004 Net Income (mil.)--   ($2.7)
2004 Employees--   19
1-Year Employee Growth--   137.5%

Website Updated... also check out thier Molecula & KD Medical website's.

http://www.calbatech.com/

http://www.molecula.com/

http://www.kdmedical.com/new_index.asp